This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Oxford University Innovation Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Journey of Tharindi Panduwawala
Introduction
Tharindi Panduwawala is a distinguished inventor based in Oxford, GB, known for his significant contributions to the field of biochemistry. His innovative work focuses on combating bacterial infections, demonstrating his commitment to advancing healthcare solutions through scientific research.
Latest Patents
Tharindi has been granted a patent for his groundbreaking invention titled "Inhibitors of Metallo-Beta-Lactamases." The patent relates to compounds of Formula (I) that serve as inhibitors of bacterial metallo-beta-lactamases. This invention outlines processes for the preparation of these compounds, along with pharmaceutical compositions that incorporate them, which can be used effectively in the treatment of bacterial infections.
Career Highlights
Tharindi is currently associated with Oxford University Innovation Limited, where he collaborates on various pioneering projects. His work is recognized for blending theoretical research with practical applications, making a tangible impact on medicine and pharmaceutical sciences.
Collaborations
Throughout his career, Tharindi has had the opportunity to work alongside esteemed colleagues such as Peter Brandt and David Wang. Their combined expertise fosters an innovative environment that cultivates the development of cutting-edge solutions in the healthcare sector.
Conclusion
Tharindi Panduwawala exemplifies the role of inventors in transforming scientific discoveries into practical applications. With his patent for inhibitors of bacterial metallo-beta-lactamases, he not only showcases his ingenuity but also highlights the importance of innovation in the ongoing fight against bacterial infections. His contributions continue to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
